| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| FTRE | FTRE | Shares | USD | XNGS |
| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| FTRE | FTRE | Shares | USD | XNGS |
Fortrea Holdings Inc. is a clinical development services company specializing in drug development for the pharmaceutical and biotechnology industries. It provides a range of services including operational leadership for clinical trials, regulatory consulting, market access strategy, and medical monitoring, with a focus on oncology and immuno-oncology. Fortrea operates globally, supporting clients in advancing their drug development programs through various phases of clinical trials, from early-phase studies to late-phase implementations.
No recent RNS announcements for FTRE across FTRE.
No recent RNS announcements for FTRE across FTRE.